Methodological issues for using a common data model (CDM) of COVID-19 vaccine uptake and important adverse events of interest (AEIs): the Data and Connectivity COVID-19 Vaccines Pharmacovigilance (DaC-VaP) United Kingdom feasibility study

Gayathri Delanerolle, Robert Williams, Ana Stipancic, Rachel Byford, Anna Forbes, Sneha Anand, Declan Bradley, Ruby Tsang, Siobhán Murphy, Ashley Akbari, Stuart Bedston, Ronan Lyons, Rhiannon Owen, Jillian Beggs, Antony Chuter, Domnique Balharry, Mark Joy, Aziz Sheikh, F D Richard Hobbs, Simon de Lusignan

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Methodological issues for using a common data model (CDM) of COVID-19 vaccine uptake and important adverse events of interest (AEIs): the Data and Connectivity COVID-19 Vaccines Pharmacovigilance (DaC-VaP) United Kingdom feasibility study'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science